RMC No. 59-2025: VAT-Exempt Medicines List Updated for Cancer, Diabetes, Hypertension, Kidney Disease, and Tuberculosis Products

RMC No. 59-2025 updates VAT-exempt medicines for key diseases, with effectivity tied to FDA Advisory issuance and proper product validation. Businesses dealing in medicines for cancer, diabetes, hypertension, kidney disease, and tuberculosis must immediately check whether their covered products are included in the updated VAT-exempt medicines list endorsed by the Food and Drug Administration. RMC […]

RMC No. 100-2024: FDA-Endorsed Updates to VAT-Exempt Medicines for Cancer, Diabetes, Hypertension, Kidney Disease, Mental Illness, and Tuberculosis

RMC No. 100-2024 publishes FDA updates to VAT-exempt medicines and confirms exemption applies from the FDA publication date of the updated list. Businesses selling, purchasing, prescribing, distributing, or accounting for covered medicines must immediately check whether their products are included in the updated FDA-endorsed list of VAT-exempt products, because VAT exemption under RMC No. 100-2024 […]